BioSpace News Archive

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, provided a business update and reported financial results for the third quarter of 2021.

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics to benefit people with rare metabolic diseases, announced that seven abstracts will be presented at the 14th International Congress of Inborn Errors of Metabolism 2021 being held November 21-23, 2021.

Grey Wolf Therapeutics, a biotechnology company spearheading a new therapeutic approach to immuno-oncology driven by targeted neoantigen generation, announced that preclinical in vivo data on the company’s first-in-class inhibitors of ERAP1 will be presented at the 36th Annual Meeting of the Society for Immunotherapy of Cancer.

AriBio, a clinical-stage biopharmaceutical company based in South Korea, announced , the topline results from its phase 2 study of AR1001 in mild to moderate Alzheimer’s disease patients.

2seventy bio, Inc. today announced its official launch as an independent, publicly traded company. 2seventy bio will trade on the Nasdaq Global Select Market, commencing tomorrow, November 5 under the ticker symbol “TSVT.”

The Trendlines Group Ltd. is pleased to announce the 100% acquisition of its 26.9%-owned portfolio company, OrthoSpin Ltd., by Synthes GMBH for a total of US$79.5 million in cash, payable in full upon closing.

Zealand Pharma A/S a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, announced that it will host a conference call on November 11, 2021 at 4 pm CET following the announcement of results for the third quarter of 2021.

Berkeley Lights, Inc., a leader in Digital Cell Biology, reported financial results for the quarter ended September 30, 2021.

DaVita Clinical Research will present eight research abstracts from company representatives and medical professionals during the American Society of Nephrology Kidney Week occurring Nov. 4–7, 2021.